Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have more belly fat and higher insulin levels, but belly fat isn't the only cause of their insulin resistance.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Metformin lowers prolactin in men with normal hair but not in those with early hair loss.

PRP therapy may increase hair density in pattern hair loss without serious side effects, but more research is needed.

Platelet-rich plasma might be a new way to treat lichen planopilaris.

Platelet-Rich Plasma (PRP) shows promise for treating various skin conditions, but more research is needed to standardize its use.

Lower TNF-α levels in PRP may predict better treatment outcomes for bladder conditions.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Balding and low testosterone increase risk of urinary stones.

Adenosine helps hair grow longer and stronger by boosting certain growth factors and signaling pathways.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

A low-starch/low-dairy diet may help overweight women with PCOS lose weight and improve metabolism, but more research is needed.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Androgenetic alopecia is linked to insulin resistance and hormonal imbalances.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

Metformin helps reduce PCOS-related infertility by improving insulin sensitivity and inducing ovulation.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.